Gene · 2823
Papers1,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 1,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pan-cancer analysis reveals potential immunological and prognostic roles of METTL7A in human cancers. | Sci Rep | 2024 | 38342956 | PubTator, text mining | PubMed |
| METTL16 inhibits papillary thyroid cancer tumorigenicity through m6A/YTHDC2/SCD1-regulated lipid metabolism. | Cell Mol Life Sci | 2024 | 38334797 | PubTator, text mining | PubMed |
| The epigenetic downregulation of LncGHRLOS mediated by RNA m6A methylase ZCCHC4 promotes colorectal cancer tumorigenesis. | J Exp Clin Cancer Res | 2024 | 38326863 | PubTator, text mining | PubMed |
| IGF2BP2-m6A-circMMP9 axis recruits ETS1 to promote TRIM59 transcription in laryngeal squamous cell carcinoma. | Sci Rep | 2024 | 38321126 | PubTator, text mining | PubMed |
| M6A methylation-regulated autophagy may be a new therapeutic target for intervertebral disc degeneration. | Cell Biol Int | 2024 | 38317355 | PubTator, text mining | PubMed |
| A Novel Signature Based on m6A Regulator-Mediated Genes Along Glycolytic Pathway Predicts Prognosis and Immunotherapy Responses of Gastric Cancer Patients. | Adv Biol (Weinh) | 2024 | 38314942 | PubTator, text mining | PubMed |
| N6-methyladenosine mRNA methylation positively regulated the response of poplar to salt stress. | Plant Cell Environ | 2024 | 38314665 | PubTator, text mining | PubMed |
| Identification of the reporter gene combination that shows high contrast for cellular level MRI. | PLoS One | 2024 | 38300967 | PubTator, text mining | PubMed |
| HIF-1A as a prognostic biomarker related to invasion, migration and immunosuppression of cervical cancer. | Heliyon | 2024 | 38298716 | PubTator, text mining | PubMed |
| Oncometabolite 2-hydroxyglutarate regulates anti-tumor immunity. | Heliyon | 2024 | 38293535 | PubTator, text mining | PubMed |
| YTHDF2-mediated circYAP1 drives immune escape and cancer progression through activating YAP1/TCF4-PD-L1 axis. | iScience | 2024 | 38292420 | PubTator, text mining | PubMed |
| Understanding YTHDF2-mediated mRNA Degradation By m6A-BERT-Deg. | ArXiv | 2024 | 38292306 | PubTator, text mining | PubMed |
| Bioinformatic identification reveals a m6A-binding protein, IGF2BP2, as a novel tumor-promoting gene signature in thyroid carcinoma. | Naunyn Schmiedebergs Arch Pharmacol | 2024 | 38289368 | PubTator, text mining | PubMed |
| Glutathione supplementation improves fat graft survival by inhibiting ferroptosis via the SLC7A11/GPX4 axis. | Stem Cell Res Ther | 2024 | 38287398 | PubTator, text mining | PubMed |
| The m6A methyltransferase RBM15 affects tumor cell stemness and progression of cervical cancer by regulating the stability of lncRNA HEIH. | Exp Cell Res | 2024 | 38280435 | PubTator, text mining | PubMed |
| Compression Promotes the Osteogenic Differentiation of Human Periodontal Ligament Stem Cells by Regulating METTL14-mediated IGF1. | Curr Stem Cell Res Ther | 2024 | 38279741 | PubTator, text mining | PubMed |
| Single-cell N6-methyladenosine-related genes function within the tumor microenvironment to affect the prognosis and treatment sensitivity in patients with gastric cancer. | Cancer Cell Int | 2024 | 38273348 | PubTator, text mining | PubMed |
| The m6A demethylase FTO targets POLQ to promote ccRCC cell proliferation and genome stability maintenance. | J Cancer Res Clin Oncol | 2024 | 38270643 | PubTator, text mining | PubMed |
| HNRNPA2B1 promotes oral squamous cell carcinogenesis via m6A-dependent stabilization of FOXQ1 mRNA stability. | IUBMB Life | 2024 | 38265150 | PubTator, text mining | PubMed |
| The m6A demethylases FTO and ALKBH5 aggravate the malignant progression of nasopharyngeal carcinoma by coregulating ARHGAP35. | Cell Death Discov | 2024 | 38263362 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2823/papers?page=15